Breath test and antibiotics aim to slash stomach cancer in indigenous communities

NCT ID NCT03900910

Recruiting now Prevention Sponsor: National Taiwan University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This program offers a simple breath test to 50,000 Aboriginal people in remote Taiwan to detect H. pylori, a bacteria linked to stomach cancer. Those who test positive receive treatment to wipe out the infection. The goal is to see if this approach lowers cancer rates in a high-risk population.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: H. pylori eradication treatment
What this could lead to: If successful, this program could significantly reduce gastric cancer rates in high-risk Indigenous populations through early detection and treatment of H. pylori infection.
What could go wrong: This is a large screening program, not a controlled trial, so results may be influenced by participation rates and reinfection. Long-term cancer reduction is not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric neoplasm gastric cancer prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRIC CANCER

Contacts and locations

Locations

National Taiwan University Hospital
RECRUITING

Taipei, Taiwan, 10002, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.